Bypassing Immunization: Optimized Design of Designer T Cells against CEA expressing Tumors

  • Yun Chae-Ok (Yonsei Cancer Center, Institute for Cancer Research, Yonsei University College of Medicine, Korea) ;
  • Nolan Kath F. (Biotherapeutics Development Lab, Harvard Institute of Human Genetics, Harvard Medical School, and Division of Hematology-Oncology, Beth Israel Deaconess Medical Center) ;
  • Akamatsu Yoshiko (Biotherapeutics Development Lab, Harvard Institute of Human Genetics, Harvard Medical School, and Division of Hematology-Oncology, Beth Israel Deaconess Medical Center) ;
  • Junghans Richard P. (Biotherapeutics Development Lab, Harvard Institute of Human Genetics, Harvard Medical School, and Division of Hematology-Oncology, Beth Israel Deaconess Medical Center)
  • Published : 2000.10.01